News | ASTRO | August 11, 2021

 

ASTRO’s 63rd Annual Meeting is scheduled to take place as an in-person meeting October 24-27 in Chicago, but be sure to bring along your masks

ASTRO’s 63rd Annual Meeting is scheduled to take place as an in-person meeting October 24-27 in Chicago, but be sure to bring along your masks

Getty Images


August 11, 2021 — ASTRO announced that it is facilitating measures that seek to ensure optimal health and sanitary conditions in all environments where in-person interactions take place during the 2021 ASTRO Annual Meeting. To assist in ensuring the safety of all attendees and exhibitors ASTRO will be requiring all attendees and exhibit booth personnel to attest that they have been fully vaccinated against COVID-19 prior to their attendance. In cases where a medical condition does not allow for vaccination, a negative COVID-19 test within 72 hours of arrival to the convention center will be required.  

In addition, all attendees and exhibitor booth personnel will be required to wear a mask while in the convention center, Exhibit Hall and ASTRO shuttle buses, except when eating or presenting. ASTRO is working with the city of Chicago and will follow or exceed all recommended Centers for Disease Control and Prevention (CDC) safety protocols and will comply with all federal, state and city regulations. ASTRO will continue to closely monitor all guidelines and regulations and will update these safety protocols as appropriate. Attendees, staff, exhibitors, exhibitor appointed contractors, vendors and members of the labor force should stay home if they have tested positive for COVID-19, are waiting for their COVID-19 test results, have COVID-19 symptoms, or if they have been in close contact with a person who has tested positive for or who has symptoms of COVID-19.

ASTRO will continue to monitor federal, state and local recommendations and will update these protocols and measures as appropriate. Updates can be found at: www.astro.org/safety


Related Content

Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Computed Tomography (CT)

July 15, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 15, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Feature | SCCT | by Christine Book

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

Time June 27, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
Subscribe Now